Evidence map›Paper›PMID 42042342›Full record

ReviewJournal of fungi (Basel, Switzerland)2026

Alessandra Vaccaro, John F Cooper, Augusto Vazquez-Rodriguez, Hamid Badali, Ryan Kean, Gordon Ramage, Jose L Lopez-Ribot

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. ER stress selects forFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alessandra VaccaroDepartment of Molecular Microbiology & Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.
John F CooperSchool of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, UK.
Augusto Vazquez-RodriguezDepartment of Molecular Microbiology & Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.
Hamid BadaliDepartment of Molecular Microbiology & Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0002-6010-8414
Ryan KeanSchool of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, UK.ORCID 0000-0001-6636-4278
Gordon RamageSchool of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, UK.
Jose L Lopez-RibotDepartment of Molecular Microbiology & Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0003-1992-3270

Funding

Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading CandidatesR33AI140823 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L., WORMLEY, FLOYD L. · 2021 to 2023
$1.3M
IbioIC, Remora and Glasgow Caledonian University PhD funded studentship No numberMargaret Batts Tobin Foundation No numberNational Institute of Allergy and Infectious Diseases R33AI140823NHS Assure Scotland ENU129NIAID NIH HHS R33 AI140823
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal drug resistancebiofilmsCandidozyma aurispathogenesis

Identifiers

PMID42042342
PMCPMC13117476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.